ShareValue scores for MRAI: Valuation 51, Quality 37, Growth 34, Health 55.

Marpai Inc logo

MRAI
NASDAQ

Marpai Inc

$2.16(-3.57%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 16%
Valuation
51
Fair Value
Price vs Value
Quality
37
Weak
Business Strength
Growth
34
Weak
Revenue & Earnings
Health
55
Moderate
Financial Stability
Momentum
100
Bullish
Price Trend

Company Details

About

Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company provides health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026